P2.08.42 Impact of Delayed Initiation of Adjuvant Chemotherapy on Overall Survival Among Patients With Non-Small Cell Lung Cancer

Esin C. Namoglu; E. Lyle Cain; Ruxandra Nicolae; Omar M Yaghi; Juan Carlos Vera; E. G. Knox; Kaitlyn Mortman; Prashanth Ashok Kumar; Scott Ely

doi:10.1016/j.jtho.2025.09.676

Related publications

Article2015

Immunogenic cell death-related biomarkers: Impact on the survival of breast cancer patients after adjuvant chemotherapy

Sylvain Ladoire, David Enot, Fabrice André, Laurence Zitvogel, Guido Guido Kroemer

Article2016

Calreticulin expression: Interaction with the immune infiltrate and impact on survival in patients with ovarian and non-small cell lung cancer

Gautier Stoll, Kristina Iribarren, Judith Michels, Alexandra Léary, Laurence Zitvogel, Isabelle Cremer, Guido Guido Kroemer

Article2003

Randomised trials comparing chemotherapy regimens for advanced non-small cell lung cancer

John P A Ioannidis, Anastasia Polycarpou, Christos Ntais, Nicholas Pavlidis

Article2020

Vemurafenib in non-small-cell lung cancer patients with BRAFV600 and BRAFnonV600 mutations

Julien Mazières, Claire Cropet, Laure Montané, Fabrice Barlési, P.-J. Souquet, Xavier Quantin, Catherine Dubos‐Arvis, Josiane Otto, Laure Favier, Virginie Avrillon, J. Cadranel, Denis Moro‐Sibilot, I. Monnet, Virginie Westeel, J. Le Treut, Étienne Brain, Jean Trédaniel, M. Jaffro, S. Collot, G. Ferretti, Céline Tiffon, Céline Mahier‐Ait Oukhatar, Jean Yves Blay

Article2024

A two‐phase epigenome‐wide four‐way gene–smoking interaction study of overall survival for early‐stage non‐small cell lung cancer

Leyi Chen, Xiang Wang, Ning Xie, Zhongwen Zhang, Xiaowen Xu, Maojie Xue, Yuqing Yang, Liya Liu, Li Su, Maria Moksnes Bjaanæs, Anna Karlsson, Maria Planck, Johan Staaf, Åslaug Helland, Manel Esteller, David C. Christiani, Feng Chen, Ruyang Zhang